Aptose Biosciences's total assets for Q4 2023 were $12.99M, a decrease of -37.78% from the previous quarter. APTO total liabilities were $15.89M for the fiscal quarter, a 21.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.